Mednet Logo
HomeNephrology
Nephrology

Nephrology

Clinical discussions on kidney disease management, dialysis, transplantation, and electrolyte disorders.

Recent Discussions

How do you decide on the speed and target of blood pressure reduction for spontaneous intracranial hemorrhage?

3
4 Answers

Mednet Member
Mednet Member
Neurology · HCA Houston Healthcare

I think the target and speed of blood pressure reduction in ICH depend on several variables, including initial SBP, clinical stability, hematoma size, and renal function. For patients presenting with SBP >220, I typically aim to lower the pressure to around SBP 160 over the first 12 hours, then grad...

When giving albumin challenge, for acute kidney injury with suspected hepatorenal syndrome, do you administer a single dose daily or split the dose of albumin?

2
1 Answers

Mednet Member
Mednet Member
Hepatology · UCLA

The main concern about albumin infusions is the potential risk for pulmonary edema (China et al., PMID 33657293). Therefore, I prefer to have albumin administered in divided doses of 25 grams at a time with a max daily dose of up to 100 grams, and I tend to stop IV albumin if the serum albumin level...

What criteria do you use to determine if a patient with chronic asymptomatic hyponatremia is safe to proceed with surgery?

1 Answers

Mednet Member
Mednet Member
Nephrology · UCLA

A patient with chronic hyponatremia is generally considered safe to proceed with surgery when the serum sodium level is ≥ 125 mmol/L (preferably ≥ 130 mmol/L) if the level is stable and truly chronic and the patient is clinically asymptomatic. In addition, the surgical team should be advised on the ...

What drives you to choose voclospsorin over tacrolimus given the substantially higher cost?

3
2 Answers

Mednet Member
Mednet Member
Rheumatology · NYU Langone Health

In a discussion of comparing voclosporin versus tacrolimus to treat LN, I would first like to address the issue of cost. As far as any individual patient, out-of-pocket expenses may be similar for these two calcineurin inhibitors since it is often covered by insurance. Additionally, Aurinia has a ve...

Do you ever combine voclosporin and belimumab in the treatment of lupus nephritis?

3
3 Answers

Mednet Member
Mednet Member
Nephrology · The Ohio State University Wexner Medical Center

The combination of these two therapies has not yet been formally tested. Having said that, the combination has an appealing rationale. Immunologically, modulating T cells and B cells in LN seems likely to be efficacious. Beyond the immunology, there are other reasons that favor this combination. Voc...

Do you check carnitine levels for your patients on CRRT?

1 Answers

Mednet Member
Mednet Member
Nephrology · Hospital of the University of Pennsylvania

Our institution doesn’t routinely check Carnitine levels. A few years ago, we did use Carnitor supplements, but in the lack of any major clinical benefit, the practice has since been abandoned, besides many clinical nutrition formulas have carnitine.

How do you evaluate the etiology of hyponatremia in a patient with ESRD and baseline oliguria/anuria?

2
2 Answers

Mednet Member
Mednet Member
Hospital Medicine · Emory University Hospital

In patients with ESRD and baseline oliguria or anuria, hyponatremia has to be approached differently because many of the usual diagnostic and monitoring tools (urine sodium, urine osmolality, urine output) are either unavailable or misleading. The key shift is to think in terms of total body water v...

Can a dihydropyridine calcium channel blocker (CCB) like amlodipine be prescribed in addition to a non-dihydropyridine CCB such as diltiazem or verapamil for treating hypertension?

1
8 Answers

Mednet Member
Mednet Member
Nephrology · UAB Medicine

Yes, with extreme caution. Diltiazem and Verapamil are CYP450 inhibitors, which can interfere with the metabolism of many medications (commonly statins and calcineurin inhibitors), but also can increase levels of nifedipine and presumably other dihydropyridine CCBs, like amlodipine. Diltiazem or ver...

Do you make any dose adjustments for patients with ESKD who are on apixaban and do not otherwise meet criteria for reduced dosing?

1
3 Answers

Mednet Member
Mednet Member
Nephrology · University Of California San Francisco Medical Center At Parnassus

I do most of the time but it depends on the indication and patient's weight and age. For soft indications, I usually give 2.5 mg bid, but if there is a significant risk (stroke, clots, etc), I will give a full dose of 5 mg bid.

How do you recommend mitigating the risks of using beta blocker and clonidine therapy in combination for management of hypertension?

1
2 Answers

Mednet Member
Mednet Member
Nephrology · UAB Medicine

Beta blockers vary in lipophilicity, which affects blood-brain barrier permeability. Propranolol and metoprolol readily cross the blood-brain barrier, while other beta-blockers like nebivolol do not. The CNS side effects of fatigue, depression, and insomnia are more likely to worsen if using a lipop...